Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
Clinical trial NCT04395222 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04395222
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2022-09-28
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.